Litcius/Paper detail

JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia

Jacob M. Rosenberg, Joshua M. Peters, Travis K. Hughes, Caleb A. Lareau, Leif S. Ludwig, Lucas R. Massoth, Christina Austin‐Tse, Heidi L. Rehm, Bryan D. Bryson, Yi‐Bin Chen, Aviv Regev, Alex K. Shalek, Sarah M. Fortune, David B. Sykes

2022Med24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAplastic anemiaContext (archaeology)ImmunologyBone marrowPopulationProgenitor cellStem cellInternal medicineBiologyPaleontologyGeneticsEnvironmental healthHematopoietic Stem Cell TransplantationCytokine Signaling Pathways and InteractionsImmunodeficiency and Autoimmune Disorders
JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia | Litcius